Researchers at Stanford are devising new ways to deliver mRNA to the body to facilitate more potent and accurate treatments and vaccines.
Are ‘natural’ skin products irritating your skin?
Two Stanford Medicine dermatology experts weigh in on the possible allergies associated with "natural" skincare products.
Schrödinger’s COVID: Infected without testing positive?
Stanford pathologist speaks to the likelihood of undetectable COVID-19 and best practices for staying safe in the face of uncertainty.
Molecular makeover makes wimpy antibody a SARS-CoV-2 tackler
By harnessing an antibody most overlooked, researchers devise a new possible way to stop viruses, even as they evolve.
Stanford Medicine magazine explores the molecules within us￼
Stanford Medicine magazine explores the molecules behind human biology and how understanding them fuels medical discoveries and innovations.
Why are smokers at an increased risk for severe COVID-19?
Tobacco smoke blocks airway cells from making a protein that protects against infection by the virus that causes COVID-19.
Unleashing the immune system to fight brain cancers
Neurosurgeon Michael Lim studies how to unleash the immune system to attack a type of brain cancer called glioblastoma.
How ovarian cancers evade the immune system
A common ovarian cancer evades detection by convincing nearby immune cells to treat it as a developing fetus.
Stanford pediatrician answers COVID-19 vaccine questions
A Stanford pediatric infectious disease expert is highlighted in a new campaign to answer parents' questions about COVID-19 vaccines.
A better COVID-19 vaccine?
A new way to deliver mRNA as a COVID-19 vaccine may avoid side effects and increase customization to prevent infection.
Evading exhaustion to improve CAR-T cell therapy
'Resting' exhausted cancer-fighting immune cells enhances their tumor-killing activity, which may help people with blood and solid cancers.
Data from twins suggests that gut bacteria are important in food allergies
A Stanford-led study of twins with and without food allergies has uncovered differences in the fecal bacteria of allergic and non-allergic individuals.
Stanford nanoparticle COVID-19 vaccine shows early success in mice
Stanford University researchers have developed a nanoparticle vaccine that has shown in mouse studies to effectively build coronavirus immunities.
Excised tonsils aid study of COVID-19 vaccines, the flu and more
Stanford scientists transformed tonsils into immunology labs in a dish, aiding research to develop vaccines for COVID-19, the flu and other diseases.
How do the new COVID-19 vaccines work?
The Pfizer and Moderna COVID-19 vaccines are the first to use the RNA coding molecule to prompt our bodies to fight the virus. Here's how they work.
Bat-borne Nipah virus could help explain COVID-19
Understanding similarities between the Nipah virus and COVID-19 could provide clues for avoiding future novel virus outbreaks.